Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | BMY | AMGN | GILD | VRTX |
| Company | Orphazyme A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9060 | 43.95 | 301.00 | 65.33 | 405.97 |
| High | 0.9571 | 43.95 | 301.00 | 65.33 | 405.97 |
| Low | 0.8457 | 43.95 | 301.00 | 65.33 | 405.97 |
| Last | 0.8700 | 43.95 | 301.00 | 65.33 | 405.97 |
| Change | -0.0200 | +0.05 | +1.52 | -0.21 | +3.47 |
| % Change | -2.25% | +0.11% | +0.51% | -0.32% | +0.86% |
| Volume | 941,400 | 8,257 | 2,010 | 55,735 | 18,300 |
| 20-Day Average Volume | 1,980,090 | 13,833,888 | 2,701,696 | 7,242,742 | 1,022,745 |
| Previous Close | 0.8900 | 43.90 | 299.48 | 65.54 | 402.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 46.72 | 275.32 | 66.46 | 398.42 |
| 20-Day Raw Stochastic | 41.76% | 7.76% | 65.12% | 18.47% | 90.23% |
| 20-Day Relative Strength | 36.52% | 29.35% | 63.34% | 34.07% | 51.30% |
| Weighted Alpha | -87.89 | -36.28 | +28.54 | -20.35 | +16.28 |
| Today's Opinion | 100% Sell | 100% Sell | 40% Buy | 100% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 100% Sell | 24% Buy | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 32% Sell | 24% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +0.02% since 04/30/24 | +9.88% since 04/30/24 | +0.20% since 04/30/24 | +3.35% since 04/30/24 |
| Low | 0.8275 on 03/29/22 | 43.33 on 05/02/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 392.47 on 05/01/24 |
| High | 0.9600 on 03/29/22 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 407.59 on 05/06/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -14.36% since 04/05/24 | +11.50% since 04/05/24 | -6.10% since 04/05/24 | -0.17% since 04/05/24 |
| Low | 0.5101 on 03/14/22 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 1.3720 on 03/10/22 | 51.68 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 407.59 on 05/06/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -9.64% since 02/07/24 | +1.73% since 02/07/24 | -12.21% since 02/07/24 | -3.13% since 02/07/24 |
| Low | 0.5101 on 03/14/22 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 2.7500 on 01/03/22 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -15.95% since 11/07/23 | +11.03% since 11/07/23 | -18.95% since 11/07/23 | +7.33% since 11/07/23 |
| Low | 0.5101 on 03/14/22 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 5.4900 on 10/13/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 88,989,688 | 160,633,888 | 81,602,352 | 104,029,752 |
| Shares Outstanding, K | 35,312 | 2,027,100 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -97,010,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | N/A | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | N/A | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.68 | 0.45 | 0.60 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 04/05/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.90 | 16.71 | 16.07 | 29.84 |